Protection of Swiss albino mice against whole-body gamma irradiation by diltiazem

British Journal of Radiology

Volumn 80, Issue 950, 2007, Pages 77-84

  Nunia, V ^a   Sancheti, G ^a   Goyal, P K ^a  

^a UNIVERSITY OF RAJASTHAN   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; ERYTHROPOIETIN; GLUTATHIONE; HEMOGLOBIN; LIPID; RADIOPROTECTIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; BONE MARROW CELL; CELL COUNT; CONTROLLED STUDY; DRUG EFFICACY; ERYTHROCYTE COUNT; ERYTHROCYTE SEDIMENTATION RATE; GAMMA RADIATION; HEMATOCRIT; HEMATOLOGIC DISEASE; LEUKOCYTE COUNT; LEUKOCYTE DIFFERENTIAL COUNT; LIPID PEROXIDATION; MOUSE; NONHUMAN; RADIATION DOSE; RADIATION EXPOSURE; RADIATION PROTECTION; RADIATION SICKNESS; WHOLE BODY RADIATION; ANIMAL; DRUG SCREENING; METABOLISM; RADIATION INJURY;

ANIMALS; DILTIAZEM; DRUG EVALUATION, PRECLINICAL; ERYTHROPOIETIN; GAMMA RAYS; GLUTATHIONE; HEMATOLOGIC DISEASES; LIPID PEROXIDATION; MICE; RADIATION INJURIES, EXPERIMENTAL; RADIATION-PROTECTIVE AGENTS; WHOLE-BODY IRRADIATION;

EID: 34250183422     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/41714035     Document Type: Article

References (43)

1. Sweeney TR. A survey of compounds from the Antiradiation Drug Development Program of the US Army Medical Research and Development Command. Washington DC, MD: Walter Reed Army Institute of Research, 1979.
2. Maisin JR. Chemical radioprotection: past, present and future prospects. Int J Radiat Biol 1998;73:443-50.
3. Weiss JF, Landauer MR. Protection against ionizing radiation by antioxidant nutrients and phytochemicals. Toxicol 2003;189:1-20.
4. Brizel DM, Wasserman TH, Henke M, Strnad V, Rudat V, Monnier, et al. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol 2000;18:3339-45.
5. Schuchter LM, Glick JH. The current status of WR-2721 (Amifostine): a chemotherapy and radiation therapy protector. Biol Ther Cancer Updates 1993;3:1-10.
6. Emerit I, Oganesian N, Sarkisian T, Arutyunyan R, Pogosian A, Asrian K, et al. Clastogenic factors in the plasma of Chernobyl recovery workers: anticlastogenic effects of Gingko biloba extract. Radiat Res 1995;144:98-205.
7. Mizina T Yu, Sitnikova SG. Antiradiation activity of juice concentrate from Hippophae rhamnoides L. fruits. Rastitel'mye Resursy 1999;35:85-92.
8. Salin CA, Samantha N, Goel HC. Protection of mouse jejunum against lethal irradiation by Podophyllum hexandrum. Phytomedicine 2001;8:413-22.
9. Naylor WG. Calcium antagonists. London, UK: Academic Press, 1999..
10. Miller DD, Waters DD. Dangoisse V, David PR. Syptometic coronary artery spasm following radiotherapy for Hodgkin's disease. Chest 1983;83:284-5.
11. Floersheim GL. Calcium antagonists protect mice against lethal doses of ionizing radiation. Br J Radiol 1992;65:1025-9.
12. Floersheim GL. Radioprotective effects of calcium antagonists used alone or with other types of radioprotectors. Radiat Res 1993;133:80-7.
13. Floersheim GL, Racine C. Calcium antagonist radioprotectors do not reduce radiotherapy efficacy in three human tumor xenografts. Stranhlenther oncol 1995;171:4.3-4.7.
14. Mukherjee SK, Goel HC, Pant K, Jain V. Preventation of radiation induced taste aversion in rats. Indian J Exp Biol 1997;35:233-5.
15. Griffin KA, Picken MM, Bakris GL, Bidani AK. Class differences in the effects of calcium channel blockers in the rat remnant kidney model. Kidney Int 1999;55:1849-60.
16. Muruganandham M, Kasiviswanathan A, Jagnannantham NR, Raghunantham P, Jain V. Diltiazem enhance tumor blood flow: MRI study in a marine tumor. Int J Radiat Oncol Biol Phys 1999;43:413-21.
17. Goyal PK, Yadav R, Nunia V, Shekhawat V. Radioprotective effect of calcium channel blocker, diltiazem, on survival in gamma rays exposed mice. Rad Prot Env 2001;24:7-9.
18. Nunia, V, Goyal, PK. Prevention of gamma radiation anaemia in mice by diltiazem. J Radiat Res 2004;45:11-7.
19. Ohkhawa H, Ohishi N, Yogi K. Assay for lipid peroxidation in animal tissue by thiobarbituric acid reaction. Analyt Biochem 1979;95:351.
20. Moron MS, Depiere JW, Mannervik B. Levels of GSH, GR and GST activities in rat lung and liver. Biochemica Biophysica. Acta 1979;582:67-78.
21. Beutler E, Duron O, Kellin BM. Improved method for the determination of blood glutathione. J Lab Clin Med 1963;61:882-8.
22. Casarett AP. Radiation Biology. Englewood Cliffs, NJ: Prentice Hall Inc., 1968, 158-9.
23. Brook I, Elliott TB. Quinilone therapy in the prevention of mortality after irradiation. Radiat Res 1991;128:100-3.
24. Potton CS. A comprehensive study of the radiobiological response of the murine (BDF 1) small intestine. Int J Radiat Biol 1990;58:925-73.
25. Micke O, Haidenberger A, Auer T, Egger S, Seegenschmiedt HM, Hengster P, DeVries AF. Irradiation causes biphasic neutrophilic granulocyte phagocytic function. Strahlenther Onkol 2005;181:313-8.
26. Heda GL, Bhatia AL. Haemocytometrical changes in Swiss albino mice after intrauterine low level HTO exposure. Proc Asian Reg Conf Med Phys 1986;390.
27. Bachmann S, Le Hir M, Eckardt KU. Colcocalization of erythropoietin m RNA and ecto-5′-nucleotidase immunoreactivity in pertubilar cells in rat renal cortex indicate that fibroblasts produce erythropoietin. J Histochem Cytochem 1993;41:335-41.
28. Bloom W, editor. Histopathology of irradiation from external and internal sources. National Nuclear Energy Series, Div. IV, Vol. 22-I, Chapter 14. New York, NY: McGraw-Hill, 1948.
29. Bakrish GL, Shaikh M. Calcium channel blockers and progression of renal disease: clinical studies put in perspective. I Nephol 1996;9:263-5.
30. Schulman DS, Flores AR, Tugoen J, Dianzumba S, Reichek N. (1996) Antihypertensive treatment in hypertensive patients with normal left ventricular mass is associated with left ventricular remodelling and improved diastolic function. Am J Cardiol 1996;78:56-60.
31. Flemming JT, Parekh N, Steinhausen M. Calcium antagonists preferentially dilate pre-glomerular vessels of hydronephrotic kidney. Am J Physio 1987;253:1157-63.
32. Reams GP, Bawer JH. Acute and chronic effects of calcium antagonists on the essential hypertensive kidney. In: Epstein M and Loutzenhiser R, editors. Calcium antagonists and kidney. Philadelphia, PA: Hanley and Belfus, 1990; 247-256.
33. Bell PD, Kause A., Franco M. Macula densa cytosolic calcium concentration during changes in luminal fluid osmolity. Kidney Int 1988;33:150-8.
34. Colin PR and Williams GH. Advances in internal medicine. Vol. 43, Mosby-Year Book, Inc. 1998.
35. Chatterjee S, Gupta PK. Protective effect of calcium channel blocker, diltiazem against cadmium induced hepato renal dysfunction in rats. Indian J Toxicol 1994;1:41-7.
36. Patil S, Kansase A, Kulkarni PH. Antianaemic properties of ayurvedic drugs, raktavardhak, punarnavasav and navayas Louh in albino rats during phenylhydrazine induced hemolytic anaemia. Ind J Exp Bio 2000;38:253-7.
37. Pande S, Kumar A, Verma S, Kumar A, Nawalakha PL. Modification of radioresponse by certain plant extracts. Proceedings of International Symposium on Radiomodifiers in Human Health. Manipal, India, 1997.
38. Daga SS, Jain VK, Goyal PK. Radioresponse to leucocytes in peripheral blood mice against gamma irradiation and their protection by Liv. 52. Probe 1995;222-226.
39. Photis B. Erythropoietin and erythropoiesis. J Hellenic Soc Hematol 1998;1:126-31.
40. Ponka P. Tissue-specific regulation of iron metabolism and heme synthesis: distinct control mechanisms in erythroid cells. Blood 1997;89:1-25.
41. Malhotra N, Srivastava PN. Haematological effects after administration of radiophosphorus in mice: Fractionated irradiation and late effects. Radiobiol Radiother 1978;19:347-50.
42. Opie LH. Perfusion injury and its pharmacolology modification. Circul 1989;80:1049-62.
43. Koller PT. Bergmann Reduction of lipid peroxidation in refused isolated rabbit hearts by diltiazem. Circ Res 1989;65:838-46.